IT seems that Guyanese are not taking seriously enough the tremendous impact that overweight has on the two main non-communicable diseases (NCDs)primarily responsible for deaths in this country – ...

The state's obesity rate is at its highest level since 2019, ranking Michigan 33rd nationally in the latest federal data. Estimates are obesity costs the health care system almost $173 billion a year.

Eli Lilly LLY, a dominant player in the global obesity market, derives most of its revenues from its blockbuster GLP-1 medicines, Mounjaro for type II diabetes (T2D) and Zepbound for obesity. Despite ...

Omada Health hit a key profitability milestone at the end of 2025 as it brought in net income of $5 million in the fourth ...

Novo Nordisk NVO shares have plunged 22% in the past month, wiping out nearly $50 billion in market capitalization. Following the recent sell-off, triggered by a series of disappointing clinical ...

Some patients taking popular GLP-1 weight loss drugs may be able to keep the weight off while taking injections less often, ...

Eli Lilly's market share in obesity drugs exceeds 60%, but further gains may be capped as competition escalates. Read why LLY ...

In a recent review, a small group of patients received the injections less frequently but still maintained weight loss and health benefits.

We reward our dogs all the time. They follow a command, wait patiently, or just look especially cute, and we hand over a ...

The prevalence of obesity and severe obesity markedly increased among adults and children in the US from the 1970s and 1980s until now, according to two reports ...

A public health expert examines how 'The Pitt' portrays obesity with clinical dignity—and what real-world medicine often misses about weight bias and patient safety.

Pfizer Inc. is drawing on lessons learned years ago from rolling out Viagra as it maps out the launch of its first obesity medicine. The parallels between weight loss and erectile dysfunction — two ...